SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-012263
Filing Date
2022-06-28
Accepted
2022-06-28 16:01:53
Documents
12
Period of Report
2022-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K dice-20220627.htm   iXBRL 8-K 52397
  Complete submission text file 0000950170-22-012263.txt   174428

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dice-20220627_lab.xml EX-101.LAB 14010
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dice-20220627_pre.xml EX-101.PRE 10303
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dice-20220627.xsd EX-101.SCH 2493
6 EXTRACTED XBRL INSTANCE DOCUMENT dice-20220627_htm.xml XML 4942
Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40794 | Film No.: 221050052
SIC: 2834 Pharmaceutical Preparations